Susquehanna reiterates a Positive on Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL). Price target lowered from $30 to $23.

This article: 247 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE